FdaApplication
ANDA 209823
Identifiers
- fda_app_no: ANDA209823
Properties
| Property | Value |
|---|---|
| applicant_name | NOVITIUM PHARMA LLC |
| application_type | ANDA |
| approval_date | 2017-10-23 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OXYBUTYNIN CHLORIDE | OXYBUTYNIN CHLORIDE | 5MG | TABLET;ORAL |
1 product